Aspirin Use Is Protective Against Gastric Cancer in a High-Incidence Region of Central America
Regular ASA use is associated with a significant reduction in gastric cancer risk, while NSAID use showed no significant protective effect. Future research should include controlled trials, and the cost-benefit trade-off between ASA's protective effects and gastrointestinal bleeding risks.
Authors
- Douglas R. Morgan (ORCID: https://orcid.org/0000-0002-1136-0963)
- Daniela M. Montalvan-Sanchez
- Dagoberto Estévez-Ordoñez (ORCID: https://orcid.org/0000-0002-8876-1044)
- Samara Rifkin (ORCID: https://orcid.org/0000-0002-6015-7232)
- Dalton A. Norwood (ORCID: https://orcid.org/0000-0001-5408-560X)
- Ricardo L. Domínguez (ORCID: https://orcid.org/0000-0001-5171-4415)
- Eleazar E. Montalvan-Sanchez (ORCID: https://orcid.org/0000-0002-7178-0724)
- Aida Rodriguez-Murillo (ORCID: https://orcid.org/0000-0001-7553-8401)
Institutions
- University of Alabama at Birmingham Hospital (US)
- University of Michigan (US)
- University of Alabama at Birmingham (US)
- Yale University (US)
Publication Details
- Journal
- Digestive Diseases and Sciences
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1007/s10620-025-09042-7
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute
- U.S. National Library of Medicine